Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients
- 30 September 2007
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 47 (3) , 366-372
- https://doi.org/10.1016/j.jhep.2007.04.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis BHepatology, 2007
- Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral LoadGastroenterology, 2006
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- 36 Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB)Journal of Hepatology, 2005
- A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D †Hepatology, 2004
- Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxilGastroenterology, 2003
- Week 48 Resistance Surveillance in Two Phase 3 Clinical Studies of Adefovir Dipivoxil for Chronic Hepatitis BHepatology, 2003
- Subtype‐Dependent Response of Hepatitis B Virus during the Early Phase of Lamivudine TreatmentClinical Infectious Diseases, 2002
- Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?Journal of Hepatology, 2002